N/A N=2,101 The PCORnet Blood Pressure Home Monitoring Study
Hypertension
Primary: Change in Systolic Blood Pressure (SBP) — 10.8; 10.6 mmHg
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=30 Nicotinamide Riboside in Systolic Heart Failure
Heart Failure, Systolic
Primary: Incidence of Treatment-Emergent Adverse Events (Safety and Tolerability) — 3.1; 3.2 events/participant
Phase 2 N=242 A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis
Diabetic Gastroparesis · Idiopathic Gastroparesis
Primary: Change From Baseline in the American Neurogastroenterology and Motility Society Gastroparesis Cardinal Symptom Index-Daily Diary (ANMS GCSI-DD) Composite Score at Week…
Phase 2 N=49 Study of AG10 in Amyloid Cardiomyopathy
Familial ATTR-CM (ATTRm-CM, or FAC) · Wild-type ATTR-CM (ATTRwt-CM)
Primary: Change in Diastolic Blood Pressure — -3.1; -3.3; -4.3; -2.6 mm Hg
N/A N=63 Primary Care Treatment Integrating Motivation and Exposure
Stress Disorders, Post-Traumatic · Alcohol-Related Disorders
Primary: Change in Clinician Administered PTSD Scale (CAPS)-5 Severity Rating — 28.46; 33.45 score on a scale
N/A N=20 The Development of a Personalized, Real-time Intervention
Drinking, Alcohol
Primary: Drinking Motives Questionnaire-Revised (DMQ-R) Coping Motive — 2.15 score on a scale — p=<.05
Phase 2 N=141 Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH)
Infantile Hemangioma
Primary: Number of Participants With Partial Response of Hemangioma Volume as Measured by VAS (Visual Analog Scale) Within Each Treatment Arm and Compared With Untreated Controls…
N/A N=30 Clinical Description of a Bronchoscopic Approach to Ablate Lung Nodules Using the Emprint™ Ablation Catheter
Cancer, Lung · Cancer, Metastatic to Lung
Primary: Number of Participants With AEs Related to the Emprint™ Ablation Catheter Kit With Thermosphere™ Technology — 1 Participants
N/A N=136 Vitamin D Supplementation and Muscle Function in Older Adults
Neuromuscular Function
Primary: Change in Lower Extremity Muscle Power Over 12 Months — -0.10; -0.13 Watts/kg — p=0.63
Phase 2 N=226 Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
Multiple Myeloma · Diffuse Large B-Cell Lymphoma · Glioblastoma Multiforme
Primary: Part A: Number of Participants With Dose-limiting Toxicities — 0; 0; 1; 1 Participants
N/A N=112 Total Knee Replacement Component Alignment Using Manual Versus Custom Instrumentation
Osteoarthritis of Knee
Primary: Post-Operative Hip-Knee-Angle (HKA) — 2.14; 3.06 Degrees
Phase 3 N=694 Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Healthy Japanese Infants (V114-033)
Pneumococcal Infections
Primary: Percentage of Participants With Solicited Injection-Site Adverse Events — 88.2; 89.3; 81.0; 81.2 Percentage of Participants — p== 0.641
N/A N=94 Breast Versus Bottle Study
Breastfeeding · Bottle Feeding
Primary: Infant Intake During the Observed Feeding (mL) — 91.9; 87.6 mL — p=0.634
Phase 2 N=15 Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate Cancer
Castration Levels of Testosterone · Castration-Resistant Prostate Carcinoma · Prostate Carcinoma Metastatic in the Bone
Primary: Progression-free Survival — 38.5 percentage of participants
N/A N=51 Alcohol Screening and Pre-Operative Intervention Research Study
Alcohol Drinking
Primary: Mean Alcohol Weekly Use — 7.01; 6.07; 8.15; 6.44 Drinks consumed/week